These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23222531)

  • 1. Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts.
    Hassett MJ; Ritzwoller DP; Taback N; Carroll N; Cronin AM; Ting GV; Schrag D; Warren JL; Hornbrook MC; Weeks JC
    Med Care; 2014 Oct; 52(10):e65-73. PubMed ID: 23222531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting Lung and Colorectal Cancer Recurrence Using Structured Clinical/Administrative Data to Enable Outcomes Research and Population Health Management.
    Hassett MJ; Uno H; Cronin AM; Carroll NM; Hornbrook MC; Ritzwoller D
    Med Care; 2017 Dec; 55(12):e88-e98. PubMed ID: 29135771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage.
    Chawla N; Yabroff KR; Mariotto A; McNeel TS; Schrag D; Warren JL
    Ann Epidemiol; 2014 Sep; 24(9):666-72, 672.e1-2. PubMed ID: 25066409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of electronic data on chemotherapy and hormone therapy use in HMOs.
    Ritzwoller DP; Carroll N; Delate T; O'Keeffe-Rossetti M; Fishman PA; Loggers ET; Aiello Bowles EJ; Elston-Lafata J; Hornbrook MC
    Med Care; 2013 Oct; 51(10):e67-73. PubMed ID: 22531648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of NCI cancer center attendance on mortality in lung, breast, colorectal, and prostate cancer patients.
    Onega T; Duell EJ; Shi X; Demidenko E; Gottlieb D; Goodman DC
    Med Care Res Rev; 2009 Oct; 66(5):542-60. PubMed ID: 19454624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spending for Advanced Cancer Diagnoses: Comparing Recurrent Versus De Novo Stage IV Disease.
    Hassett MJ; Banegas M; Uno H; Weng S; Cronin AM; O'Keeffe Rosetti M; Carroll NM; Hornbrook MC; Ritzwoller DP
    J Oncol Pract; 2019 Jul; 15(7):e616-e627. PubMed ID: 31107629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing non-cancer-related health status of US cancer patients: other-cause survival and comorbidity prevalence.
    Cho H; Mariotto AB; Mann BS; Klabunde CN; Feuer EJ
    Am J Epidemiol; 2013 Aug; 178(3):339-49. PubMed ID: 23825168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival after recurrence of stage I-III breast, colorectal, or lung cancer.
    Hassett MJ; Uno H; Cronin AM; Carroll NM; Hornbrook MC; Fishman P; Ritzwoller DP
    Cancer Epidemiol; 2017 Aug; 49():186-194. PubMed ID: 28710943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality rates by stage-at-diagnosis.
    Clinton K
    Semin Surg Oncol; 1994; 10(1):7-11. PubMed ID: 8115787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Evaluation of Algorithms for Identifying Metastatic Breast, Lung, or Colorectal Cancer in Administrative Claims Data.
    Whyte JL; Engel-Nitz NM; Teitelbaum A; Gomez Rey G; Kallich JD
    Med Care; 2015 Jul; 53(7):e49-57. PubMed ID: 23524464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare Spending for Breast, Prostate, Lung, and Colorectal Cancer Patients in the Year of Diagnosis and Year of Death.
    Chen CT; Li L; Brooks G; Hassett M; Schrag D
    Health Serv Res; 2018 Aug; 53(4):2118-2132. PubMed ID: 28748564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of warfarin therapy on breast, colorectal, lung, and prostate cancer survival: a population-based cohort study using the Clinical Practice Research Datalink.
    O'Rorke MA; Murray LJ; Hughes CM; Cantwell MM; Cardwell CR
    Cancer Causes Control; 2015 Mar; 26(3):355-66. PubMed ID: 25534917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of administrative claims data for the study of brain metastases: a validation study.
    Eichler AF; Lamont EB
    J Neurooncol; 2009 Dec; 95(3):427-431. PubMed ID: 19562256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of patients newly diagnosed with colorectal cancer and with a history of previous cancer.
    Pruitt SL; Gerber DE; Zhu H; Heitjan DF; Maddineni B; Xiong D; Singal AG; Tavakkoli A; Halm EA; Murphy CC
    Cancer Med; 2021 Jul; 10(14):4752-4767. PubMed ID: 34190429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of ICD-9-CM codes for breast, lung and colorectal cancers in three Italian administrative healthcare databases: a diagnostic accuracy study protocol.
    Abraha I; Serraino D; Giovannini G; Stracci F; Casucci P; Alessandrini G; Bidoli E; Chiari R; Cirocchi R; De Giorgi M; Franchini D; Vitale MF; Fusco M; Montedori A
    BMJ Open; 2016 Mar; 6(3):e010547. PubMed ID: 27016247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial/ethnic disparities in de novo metastases sites and survival outcomes for patients with primary breast, colorectal, and prostate cancer.
    Akinyemiju T; Sakhuja S; Waterbor J; Pisu M; Altekruse SF
    Cancer Med; 2018 Apr; 7(4):1183-1193. PubMed ID: 29479835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of algorithms using administrative health and structured electronic medical record data to determine breast and colorectal cancer recurrence in a Canadian province : Using algorithms to determine breast and colorectal cancer recurrence.
    Lambert P; Pitz M; Singh H; Decker K
    BMC Cancer; 2021 Jul; 21(1):763. PubMed ID: 34210266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with self-reported falls, balance or walking difficulty in older survivors of breast, colorectal, lung, or prostate cancer: Results from Surveillance, Epidemiology, and End Results-Medicare Health Outcomes Survey linkage.
    Huang MH; Blackwood J; Godoshian M; Pfalzer L
    PLoS One; 2018; 13(12):e0208573. PubMed ID: 30566443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the estimation of survival.
    Henson DE; Ries LA
    Semin Surg Oncol; 1994; 10(1):2-6. PubMed ID: 8115782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of case-finding algorithms for recurrence of breast cancer using routinely collected administrative data.
    Xu Y; Kong S; Cheung WY; Bouchard-Fortier A; Dort JC; Quan H; Buie EM; McKinnon G; Quan ML
    BMC Cancer; 2019 Mar; 19(1):210. PubMed ID: 30849954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.